北京大学基础医学院

院长论坛

        报告题目：Connecting genomics research to new understanding of autoimmune disease cause and management

　　报 告 人：Professor Kathy Siminovitch

　　                   Samuel Lunenfeld Research Institute

　　                   University of Toronto

　　时    间：2013年4月1日（星期一）上午10:30

　　地    点：医学部生化楼三楼中厅

　　主 持 人：张毓 教授

　　报告人简介:

　　Dr. Siminovitch is a Professor of Medicine at the University of Toronto and serves as the Director of the Lunenfeld’s Genomic Medicine Program at Mount Sinai Hospital.  Her research program is directed at identifying the molecular factors which regulate normal immune responses and which, when disrupted, result in immune deficiency or autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease. Dr. Siminovitch was awarded a Canada Research Chair in Immunogenomics (2005) and has received a CIHR Senior Scientist Award (2000-2005), an Arthritis Society of Canada Research Scientist Award (1992-2001), an Ontario Ministry of Health Cancer Scientist Award (1986-1996) and the Canadian Life and Health Association Medical Scholarship (1986-1992). Some of her recent publications include:

　　l         The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness. Nat Genet. 2011;43(9):902-7.

　　l         Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis. Nat Genet. 2010;42(8):655-7.

　　l         REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis. Nat Genet. 2009l;41(7):820-3.

　　l         Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med. 2009;360(24):2544-55.